MedPath

Controlling antibiotic resistance through education of mothers and healthcare providers to reduce the unnecessary use of antibiotics in pregnancy, childbirth and for young childre

Not Applicable
Conditions
Antibiotic use and antibiotic resistance among pregnant women and children under 2 years of age
Infections and Infestations
Resistance to antibiotics
Registration Number
ISRCTN16217522
Lead Sponsor
Karolinska Institute
Brief Summary

2020 protocol in https://pubmed.ncbi.nlm.nih.gov/33427692/ (added 07/01/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
800
Inclusion Criteria

Pregnant women/mothers:
1. 3rd trimester on enrolment and who, after the enrolment, plan to stay in the area for the next 24 months
2. Whose infants are born during the study period
3. Willing to participate in the study

Healthcare providers (HCPs):
1. All medical doctors, assistant doctors, midwives, nurses, pharmacists, assistant pharmacists at the Vientiane provincial hospital, district hospitals or health centres in Feuang or Vangvieng as well as pharmacists and assistant pharmacists at private pharmacies in these districts.
2. Some HCPs will be invited to participate in individual qualitative interviews:
2.1. Private providers (in private clinics and pharmacies) in the study area
2.2. Representatives from central level such as Ministry of Health, university and professional organizations
2.3. Providers from the public healthcare facilities involved
2.4. HCPs and policy makers from the Maternal and New-born Hospital (MNH) in Vientiane capital, where women from different parts of the country come for ANC and consultation

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of uncomplicated normal deliveries for which antibiotics were used measured using data on antibiotic use for each delivery collected continuously from patient records for 27 months: from 12 months before the intervention, during the intervention (3 months), and 12 months after the intervention.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath